Gloria Ying: Announcement on Launching Foreign Exchange Derivatives Trading Business
Gloria Ying: Announcement on the 2024 Remuneration Plan for Directors, Supervisors, and Senior Managers
Gloria Ying: 2023 Goodwill Impairment Test Report
Gloria Ying: Internal Control Self-Assessment Report
Gloria Ying: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Gloria Ying: 2023 Financial Results Report
Gloria Ying: Announcement on Appointment of Chief Operating Officer
Gloria Ying: Announcement on Promoting the Implementation of the Action Plan to Double Improve Quality and Return
Gloria Ying: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders, the 2024 Second Class A Share Shareholders' Meeting, and the 2024 Second Class H Shareholders' Meeting
Gloria Ying: Legal Opinions on the 2024 Second Extraordinary General Meeting of Shareholders of Gloria Pharmaceutical Group (Tianjin) Co., Ltd., the 2024 Second Class A Shareholders' Meeting, and the 2024 Second Class H Shareholders' Meeting
Gloria Ying: Notice on the holding of the 2024 Second Extraordinary General Meeting of Shareholders, the 2024 Second Class A Share Shareholders\' Meeting, and the 2024 Second Class H Shareholders\' Meeting
Gloria Ying: Announcement on the Resignation of the Company\'s Independent Director and the By-election of Independent Director Candidates
Gloria Ying: Prompt Announcement on Postponing the General Election of the Board of Directors and the Board of Supervisors
Gloria Ying: Legal Opinions on the 2024 First Extraordinary General Meeting of Shareholders of Gloria Pharmaceutical Group (Tianjin) Co., Ltd., the 2024 First Class A Shareholders\' Meeting, and the 2024 First Class H Shareholders\' Meeting
Gloria Ying: Announcement on Adjusting the 2022 Employee Stock Ownership Plan Management Committee Members
Gloria Ying: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders, the 2024 First Class A Share Shareholders\' Meeting, and the 2024 First Class H Shareholders\' Meeting
Gloria Ying: Announcement on the repurchase and cancellation of restricted stock incentive plans to reduce registered capital for some restricted stocks and notify creditors
Gloria Ying: Notice on the holding of the 2024 First Extraordinary General Meeting of Shareholders, the 2024 First Class A Share Shareholders\' Meeting, and the 2024 First Class H Shareholders\' Meeting
Gloria Ying: “Gloria Young Pharmaceutical Group (Tianjin) Co., Ltd. Whistleblowing Policy”
Gloria Ying: “Rules of Procedure for the Board of Directors of Gloria Pharmaceutical Group (Tianjin) Co., Ltd.”
No Data